To support this presumption, growing evidence has described that in human patients, a polymorphism in CNR1 and CNR2 is associated with schizophrenia, autism, depression, anxiety, bipolar disorder, and depressive syndrome [292,293,294,295,296]. This evidence concerns the gene CNR2 and depressive symptom measurement.